Periosteum-derived mesenchymal stem cell alleviates renal fibrosis through mTOR-mediated Treg differentiation

BACKGROUND: Mesenchymal stem cells (MSCs) are the hotspots of cellular therapy due to their low immunogenicity, potent immunoregulation, and unique renoprotection. The present study aimed to investigate the effects of periosteum-derived MSCs (PMSCs) in ischemia–reperfusion (IR)-mediated renal fibros...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Yongsheng, Zhang, Kuanxin, Wu, Jiaheng, Zeng, Hao, Chen, Juntao, Zhang, Pingbao, Guo, Jingjing, Xu, Cuidi, Niu, Xinhao, Cheuk, Yin Celeste, Xu, Shihao, Cao, Yirui, Zhao, Yufeng, Zhu, Dong, Wang, Xuanchuan, Rong, Ruiming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10208165/
https://www.ncbi.nlm.nih.gov/pubmed/37218597
http://dx.doi.org/10.1080/0886022X.2023.2212079

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10208165/
https://www.ncbi.nlm.nih.gov/pubmed/37218597
http://dx.doi.org/10.1080/0886022X.2023.2212079

Ejemplares similares